Role of miR-21 in the pathogenesis of atrial fibrosis
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · cited 2×
“Increasing evidence identifies human miRNAs as key regulators of genetic programmes in cardiovascular biology [8, 11, 12, 20, 30, 33, 40, 59, 63, 65].”
BackgroundThe functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728 · cited 2×
“To further study the mechanism of the regulation of miR21 expression by AngII and CTGF, we tested the effect of stimulation with these known activators of the lysyl oxidase, on the expression of Dicer and Drosha, which are important endonucleases for miR generation [5, 17, 30, 31].”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“called antagomirs [29].”
BackgroundMicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349 · cited 3×
“Recent evidence shows that the microRNA-21 (miR-21) and its downstream target Sprouty1 (Spry1), a potent inhibitor of the Ras/MEK/ERK pathway [13, 23, 44, 64] play a role in the pathogenesis of ventricular fibrosis in patients with congestive heart failure [60].”
BackgroundSelf-citationSmall silencing RNAs: an expanding universe
Ghildiyal, M., & Zamore, P. D. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2504 · Cited by 2,325
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Self-citationNew ideas about atrial fibrillation 50 years on
Nattel, S. (2002) · Nature · doi:10.1038/415219a · Cited by 1,481
Electrical, contractile and structural remodeling during atrial fibrillation
Allessie, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00258-4 · Cited by 1,449
Promotion of Atrial Fibrillation by Heart Failure in Dogs: Atrial Remodeling of a Different Sort
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,341
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Nattel, S., Burstein, B., & Dobrev, D. (2008) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.107.754564 · Cited by 1,124
Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell
Kagan, H. M., & Li, W. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10413 · Cited by 954
Landthaler, M., Yalcin, A., & Tuschl, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.001 · Cited by 850
microPrimer: the biogenesis and function of microRNA
Du, T., & Zamore, P. D. (2005) · Development · doi:10.1242/dev.02070 · Cited by 813
Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis
Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007) · Circulation Research · doi:10.1161/circresaha.107.153916 · Cited by 786
Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y., & Krasnow, M. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80919-8 · Cited by 749
Li, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 703
Lysyl oxidase: Properties, regulation and multiple functions in biology
Smith-Mungo, L. I., & Kagan, H. M. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90012-9 · Cited by 578
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
Hanafusa, H., Torii, S., Yasunaga, T., & Nishida, E. (2002) · Nature Cell Biology · doi:10.1038/ncb867 · Cited by 566 · cited 1×
“Recent evidence shows that the microRNA-21 (miR-21) and its downstream target Sprouty1 (Spry1), a potent inhibitor of the Ras/MEK/ERK pathway [13, 23, 44, 64] play a role in the pathogenesis of ventricular fibrosis in patients with congestive heart failure [60].”
BackgroundRecent advances in the molecular pathophysiology of atrial fibrillation
Wakili, R., Voigt, N., Kääb, S., Dobrev, D., & Nattel, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46315 · Cited by 545
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 491
Mäki, J. M., Räsänen, J., Tikkanen, H., Sormunen, R., Mäkikallio, K., Kivirikko, K. I., & Soininen, R. (2002) · Circulation · doi:10.1161/01.cir.0000038109.84500.1e · Cited by 482
Sprouty, an intracellular inhibitor of Ras signaling
Casci, T., Vinós, J., & Freeman, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80576-0 · Cited by 467 · cited 1×
“Recent evidence shows that the microRNA-21 (miR-21) and its downstream target Sprouty1 (Spry1), a potent inhibitor of the Ras/MEK/ERK pathway [13, 23, 44, 64] play a role in the pathogenesis of ventricular fibrosis in patients with congestive heart failure [60].”
BackgroundBoldt, A., Wetzel, U., Lauschke, J., Weigl, J., Gummert, J., Hindricks, G., Kottkamp, H., & Dhein, S. (2004) · Heart · doi:10.1136/hrt.2003.015347 · Cited by 466
MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation
Lu, Y., Zhang, Y., Wang, N., Pan, Z., Gao, X., Zhang, F., Zhang, Y., Shan, H., Luo, X., Bai, Y., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.958967 · Cited by 451
MicroRNA-24 Regulates Vascularity After Myocardial Infarction
Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P., Kneitz, S., Pena, J. T. G., Sohn-Lee, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.039008 · Cited by 393
Self-citationMicroRNAs: novel regulators in cardiac development and disease
Thum, T., Catalucci, D., & Bauersachs, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn137 · Cited by 377
Self-citationMicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A. J. G., Vinciguerra, M., Rosenthal, N., Sciacca, S., Pilato, M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.255737 · Cited by 366
Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac Fibroblasts
Kawano, H., Do, Y. S., Kawano, Y., Starnes, V., Barr, M., Law, R. E., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1130 · Cited by 312
Lysyl Oxidase Is Required for Vascular and Diaphragmatic Development in Mice
Hornstra, I. K., Birge, S., Starcher, B., Bailey, A. J., Mecham, R. P., & Shapiro, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210144200 · Cited by 308
New antiarrhythmic drugs for treatment of atrial fibrillation
Dobrev, D., & Nattel, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60096-7 · Cited by 284
Regulation of Angiotensin II Receptor Subtypes During Atrial Fibrillation in Humans
Goette, A., Arndt, M., Röcken, C., Spiess, A., Staack, T., Geller, J. C., Huth, C., Ansorge, S., Klein, H. U., & Lendeckel, U. (2000) · Circulation · doi:10.1161/01.cir.101.23.2678 · Cited by 280
Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis
Rupérez, M., Lorenzo, O., Blanco-Colio, L. M., Esteban, V., Egido, J., & Ruiz-Ortega, M. (2003) · Circulation · doi:10.1161/01.cir.0000089129.51288.ba · Cited by 267
Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects
López, B., González, A., Hermida, N., Valencia, F., de Teresa, E., & Díez, J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2010 · Cited by 252
Structural and functional diversity of lysyl oxidase and the LOX-like proteins
Molnar, J., Fong, K. S. K., He, Q. P., Hayashi, K., Kim, Y., Fong, S. F. T., Fogelgren, B., Molnarne Szauter, K., Mink, M., & Csiszar, K. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00053-0 · Cited by 251
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation
Girmatsion, Z., Biliczki, P., Bonauer, A., Wimmer-Greinecker, G., Scherer, M., Moritz, A., Bukowska, A., Goette, A., Nattel, S., Hohnloser, S. H., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.08.035 · Cited by 246
Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., & Casadei, B. (2011) · Circulation · doi:10.1161/circulationaha.111.029223 · Cited by 227
Antoniades, C., Bakogiannis, C., Leeson, P., Guzik, T. J., Zhang, M.-H., Tousoulis, D., Antonopoulos, A. S., Demosthenous, M., Marinou, K., Hale, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.985150 · Cited by 219
Impact of HMG CoA reductase inhibition on small GTPases in the heart
Laufs, U. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00540-5 · Cited by 202
Self-citationSussman, M. A., Welch, S., Walker, A., Klevitsky, R., Hewett, T. E., Price, R. L., Schaefer, E., & Yager, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8497 · Cited by 183
Novel molecular targets for atrial fibrillation therapy
Dobrev, D., Carlsson, L., & Nattel, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3682 · Cited by 181
Krijnen, P. A. J., Hahn, N. E., Kholová, I., Baylan, U., Sipkens, J. A., Alphen, F. P., Vonk, A. B. A., Simsek, S., Meischl, C., Schalkwijk, C. G., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0233-5 · Cited by 180
López, B., Querejeta, R., González, A., Beaumont, J., Larman, M., & Díez, J. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.125278 · Cited by 173
Localization and activity of lysyl oxidase within nuclei of fibrogenic cells
Li, W., Nellaiappan, K., Strassmaier, T., Graham, L., Thomas, K. M., & Kagan, H. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12817 · Cited by 167
Role of Rac1 GTPase Activation in Atrial Fibrillation
Adam, O., Frost, G., Custodis, F., Sussman, M. A., Schäfers, H.-J., Böhm, M., & Laufs, U. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.041 · Cited by 165
Self-citationAdam, O., Lavall, D., Theobald, K., Hohl, M., Grube, M., Ameling, S., Sussman, M. A., Rosenkranz, S., Kroemer, H. K., Schäfers, H.-J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.064 · Cited by 163
Self-citationMitogen-activated protein kinases in the heart
Michel, M. C., Li, Y., & Heusch, G. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000363 · Cited by 138
Antoniades, C., Bakogiannis, C., Tousoulis, D., Reilly, S., Zhang, M.-H., Paschalis, A., Antonopoulos, A. S., Demosthenous, M., Miliou, A., Psarros, C., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927376 · Cited by 124
MicroRNAs and atrial fibrillation: new fundamentals
Wang, Z., Lu, Y., & Yang, B. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq350 · Cited by 115
Boldt, A., Scholl, A., Garbade, J., Resetar, M., Mohr, F., Gummert, J. F., & Dhein, S. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0571-2 · Cited by 114
Miller, C. L., Cai, Y., Oikawa, M., Thomas, T., Dostmann, W. R., Zaccolo, M., Fujiwara, K., & Yan, C. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0228-2 · Cited by 113
Control of cardiovascular differentiation by microRNAs
Ohtani, K., & Dimmeler, S. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0139-7 · Cited by 109
Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy
Sivakumar, P., Gupta, S., Sarkar, S., & Sen, S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9595-2 · Cited by 107
Self-citationMicroRNAs: Regulating a Change of Heart
Barringhaus, K. G., & Zamore, P. D. (2009) · Circulation · doi:10.1161/circulationaha.107.715839 · Cited by 105
Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation
Adam, O., Theobald, K., Lavall, D., Grube, M., Kroemer, H. K., Ameling, S., Schäfers, H., Böhm, M., & Laufs, U. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.019 · Cited by 103
Self-citationControl of cardiac excitability by microRNAs
Yang, B., Lu, Y., & Wang, Z. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn181 · Cited by 100
Matranga, C. B., & Zamore, P. D. (2007) · Current Biology · doi:10.1016/j.cub.2007.07.014 · Cited by 94
Suenari, K., Chen, Y., Kao, Y., Cheng, C., Lin, Y., Chen, S.-A., & Chen, S.-A. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0132-1 · Cited by 89
Custodis, F., EBERL, M., Kilter, H., Böhm, M., & Laufs, U. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.04.005 · Cited by 84
Self-citationIhm, S., Chang, K., Kim, H.-Y., Baek, S. H., Youn, H., Seung, K., & Kim, J. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0071-x · Cited by 78
Hasin, T., Elhanani, O., Abassi, Z. A., Hai, T., & Aronheim, A. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0145-9 · Cited by 40
Genetic suppression of Gαs protein provides rate control in atrial fibrillation
Lugenbiel, P., Thomas, D., Kelemen, K., Trappe, K., Bikou, O., Schweizer, P. A., Voss, F., Becker, R., Katus, H. A., & Bauer, A. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0265-5 · Cited by 38
Yang, S.-S., Han, W., Cao, Y., Dong, G., Zhou, G., Li, W.-M., Gan, R.-T., Chang, H.-Y., & Wang, Z. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0154-3 · Cited by 31
Intracellular lysyl oxidase: Effect of a specific inhibitor on nuclear mass in proliferating cells
Saad, F. A., Torres, M., Wang, H., & Graham, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.028 · Cited by 31
Cited by
Atrial Remodeling and Atrial Fibrillation
Nattel, S., & Harada, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.555 · Cited by 736
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
Zhou, S.-S., Jin, J.-P., Wang, J.-Q., Zhang, Z.-G., Freedman, J. H., Zheng, Y., & Cai, L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.30 · Cited by 675
Cardiac Fibrosis in Patients With Atrial Fibrillation
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1313 · Cited by 552
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
Sagris, M., Vardas, E. P., Theofilis, P., Antonopoulos, A. S., Oikonomou, E., & Tousoulis, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010006 · Cited by 395
A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis
Liang, H., Zhang, C., Ban, T., Liu, Y., Mei, L., Piao, X., Zhao, D., Lu, Y., Chu, W., & Yang, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.019 · Cited by 169
Metadata
- Authors
- Adam, O., Löhfelm, B., Thum, T., Gupta, S. K., Puhl, S.-L., Schäfers, H.-J., Böhm, M., & Laufs, U.
- Venue
- Basic Research in Cardiology
- Published
- 2012-07-04
- Volume
- 107
- Issue
- 5
- Pages
- 278-278
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- OpenAlex
- W2027558925
- Cited by
- 255
- References
- 64
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.